Covid 19 vaccine

Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year,…

The phase-II/III clinical trial results have been published in peer-reviewed and international journal 'Vaccine'

The regulator's decision is in addition to the earlier clearance for the vaccine as a primary two-shot regimen for those aged 12…

Speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network…

The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months

The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron

The government has said that each shot contains one-tenth of the adult dosage, reducing the chance of side effects

Japan in January expanded use of the vaccine to those as young as five years old

The approval comes as somewhat of a surprise as Walvax, which has been conducting large late-stage trials of the vaccine in…

Recommendation based on Tackle phase-III treatment data showing reduced risk of severe COVID-19 or death